emerg
coronavirus
merscov
sarscov
caus
signific
morbid
mortal
infect
individu
lung
infect
common
clinic
featur
contribut
diseas
sever
well
viral
transmiss
anim
model
often
requir
studi
viral
infect
therapi
especi
initi
outbreak
histopatholog
studi
allow
identif
lesion
affect
cell
type
better
understand
viral
pathogenesi
clarifi
effect
therapi
use
immunostain
allow
detect
presum
viral
receptor
viral
tropism
cell
evalu
correl
lesion
lung
lesion
immunostain
qualit
describ
defin
cell
type
microanatom
locat
type
chang
seen
featur
import
necessari
approach
limit
compar
treatment
group
semiquantit
quantit
tissu
score
rigor
provid
abil
statist
compar
group
increas
reproduc
rigor
studi
review
describ
principl
approach
resourc
use
evalu
coronaviru
lung
infect
focus
mercov
infect
princip
exampl
emerg
coronavirus
sever
acut
respiratori
syndrom
sarscov
middl
east
respiratori
syndrom
merscov
caus
signific
impact
human
health
especi
initi
outbreak
peopl
infect
coronavirus
often
signific
lung
diseas
contribut
clinic
morbid
mortal
histopatholog
examin
immunostain
eg
immunohistochemistri
lung
tissu
essenti
better
understand
diseas
pathogenesi
evalu
novel
treatment
current
futur
viru
outbreak
focu
merscov
infect
present
import
principl
valid
qualit
quantit
evalu
infect
lung
tissu
prepar
qualiti
lung
tissu
sampl
import
histopatholog
examin
optim
preserv
fine
pulmonari
architectur
case
immunostain
antigen
target
epitop
studi
engel
moor
identifi
variabl
time
frame
begin
proper
sampl
collect
handl
includ
multipl
aspect
tissu
collect
fixat
process
embed
slide
dri
storag
thu
attent
detail
qualiti
earli
greatli
aid
subsequ
evalu
interpret
impact
tissu
examin
collect
lung
histolog
sampl
harvest
soon
possibl
follow
death
minim
autolysi
autolysi
selfdigest
postmortem
chang
character
degrad
cellular
constitu
dna
rna
protein
dissolut
tissu
caus
degrad
epitop
increas
nonspecif
stain
immunohistochemistri
autolyt
region
morpholog
confus
foci
necrosi
edema
anim
euthan
prefer
select
method
target
lung
intraven
agent
even
use
inhal
overdos
carbon
dioxid
commonli
use
rodent
potenti
caus
minor
edemahemorrhag
evalu
control
standard
evalu
antemortem
euthanasiarel
variabl
affect
lung
evalu
examin
rodent
versu
lung
larger
anim
human
sampl
becom
relev
variabl
instanc
mice
small
lung
section
onto
one
glass
slide
widespread
evalu
larger
size
lung
sampl
adequ
use
one
slide
without
introduc
sampl
bia
therefor
sever
sampl
need
collect
larger
lung
collect
method
need
defin
method
public
includ
collect
site
standard
vs
lesion
site
total
number
latter
depend
size
lung
distribut
lung
lesion
overarch
goal
studi
proper
adequ
fixat
tissu
essenti
retain
optim
tissu
morpholog
cellular
antigen
immunostain
techniqu
howev
import
rememb
lung
assess
score
macroscop
gross
indic
diseas
color
surfac
textur
consist
must
done
prior
fixat
affect
paramet
macroscop
evalu
score
nice
tool
complement
histopatholog
lesion
tissu
paraffin
embed
section
typic
fix
neutral
buffer
formalin
paraformaldehyd
though
fix
may
employ
base
desir
analysi
endpoint
collect
lung
sampl
place
minimum
volum
fix
tissu
maxim
thick
tissu
mm
least
one
dimens
consist
fix
rodent
inflat
lung
via
intratrach
instil
fix
recommend
best
preserv
lung
morpholog
reduc
artifactu
atelectasi
howev
approach
contraind
lung
infect
alter
anatom
locat
inflamm
cellular
debri
lung
heart
rodent
remov
en
bloc
fixat
freez
tissu
may
altern
approach
preserv
specif
antigen
process
typic
result
suboptim
retent
cellular
tissu
architectur
detail
process
dehydr
fix
lung
sampl
must
embed
section
consist
manner
due
rel
small
size
mice
lung
lobe
embed
en
bloc
ventral
lobar
surfac
orient
cassett
result
section
show
longitudin
view
major
conduct
airway
altern
approach
mice
standard
approach
larger
speci
lung
lobe
collect
multipl
section
fit
cassett
sampl
embed
separ
slide
typic
stain
hematoxylin
eosin
routin
histolog
evalu
immunostain
desir
essenti
optim
valid
new
antibodi
util
appropri
posit
neg
control
ensur
accur
stain
result
similarli
special
histochem
stain
employ
appropri
control
slide
tissu
also
util
batch
awar
normal
anatomi
morpholog
necessari
recogn
type
chang
util
anim
model
human
diseas
includ
know
differ
speci
exampl
number
morpholog
differ
respiratori
tract
structur
mice
human
lobat
distinct
mice
four
right
lung
lobe
cranial
middl
caudal
accessori
one
left
lobe
human
three
right
lung
lobe
upper
middl
lower
two
left
lobe
upper
lower
rat
mice
lack
intralobular
septa
intrapulmonari
bronchi
intrapulmonari
submucos
gland
respiratori
bronchiol
mice
also
club
cell
extend
trachea
thinner
bloodga
barrier
smaller
alveolar
diamet
human
anatom
variat
mean
rodent
valuabl
model
lung
diseas
rather
highlight
exampl
type
knowledg
necessari
correct
interpret
experiment
model
inclus
experienc
boardcertifi
pathologist
special
train
examin
interpret
tissu
chang
part
multidisciplinari
team
greatli
enhanc
qualiti
tissu
evalu
histopatholog
skill
eye
ideal
pathologist
familiar
model
defin
type
inflammatori
process
also
corrobor
find
clinic
sign
andor
data
analys
addit
pathologist
knowledg
correct
lesion
nomenclatur
well
potenti
effect
variabl
strainrel
background
lesion
husbandri
microbiom
diet
interpret
result
pathologist
involv
design
translat
experi
interpret
lesion
anim
model
bia
may
introduc
accuraci
data
conclus
may
question
approach
lack
expertis
pathologist
train
tissu
interpret
label
doityourself
patholog
link
multipl
public
contain
erron
interpret
observ
made
biomed
personnel
may
biolog
accur
case
import
note
tissu
examin
nonpathologist
even
scientif
expert
particular
diseas
prone
falseposit
falseneg
error
recommend
ideal
tissu
examin
pathologist
familiar
histopatholog
model
see
note
recogn
lab
access
pathologist
role
mani
situat
member
investig
team
assign
role
situat
possibl
help
pathologist
review
studi
find
prior
public
examin
meet
pathologist
screen
slide
data
accuraci
lung
uniqu
featur
compar
organ
import
consider
design
experi
make
interpret
studi
infecti
diseas
distribut
histolog
appear
lung
lesion
depend
varieti
factor
includ
viral
inocul
concentr
rout
exposur
region
deposit
cellular
uptak
chronic
host
immun
respons
instanc
inbr
mous
strain
variabl
size
airway
may
affect
viral
droplet
deliveri
clinic
diseas
manifest
airway
obstruct
inbr
mous
strain
also
exhibit
bias
eg
vs
immun
respons
defici
immun
signal
pathway
might
influenc
infect
suscept
sever
sex
also
influenc
factor
infect
need
consid
experiment
design
even
action
simpl
lay
anim
later
recumb
recov
anesthesia
follow
viral
inocul
may
lead
promin
lesion
certain
lobe
mani
featur
inclus
appropri
control
anim
ie
strain
age
sexmatch
hous
ident
husbandri
condit
free
confound
pathogen
necessari
import
teas
lesion
unrel
treatment
unlik
organ
size
rel
static
lung
dynam
size
chang
normal
respir
hand
postmortem
lung
standard
manner
use
prevent
postmortem
atelectasi
variabl
interanim
insuffl
right
ventricular
perfus
fix
lung
prior
extract
help
fixat
well
insuffl
airspac
without
dislodg
inflamm
mucocellular
debri
histopatholog
microscop
examin
tissu
morpholog
structur
chang
differ
normal
chang
call
lesion
histopatholog
coronavirusinfect
lung
human
anim
model
use
tool
help
defin
affect
cell
illumin
structur
caus
clinic
sign
clarifi
potenti
therapi
diseas
outbreak
clinic
data
includ
autopsi
case
studi
parallel
anim
model
investig
better
defin
lung
diseas
pathogenesi
therapi
instanc
novel
human
coronaviru
known
merscov
first
isol
patient
die
saudi
arabia
region
outbreak
local
burial
ritual
along
requir
high
biosecur
constrain
autopsi
studi
perform
first
report
earli
within
year
first
report
merscov
case
human
sever
anim
model
studi
model
provid
much
initi
critic
import
lung
patholog
data
histopatholog
examin
viral
lung
infect
requir
awar
anticip
lesion
clinic
publish
data
avail
exampl
merscov
lesion
list
tabl
instanc
acut
diffus
alveolar
damag
dad
common
featur
merscov
lung
lesion
compos
lesion
edema
inflamm
alveolar
septal
injuri
awar
report
lesion
help
guid
pathologist
examin
also
use
consist
method
examin
experiment
tissu
avoid
unintent
bia
might
caus
failur
detect
unexpect
lesion
consist
examin
tissu
control
treatment
group
reduc
chanc
mistakenli
diagnos
nonspecif
model
background
phenotyp
merscovspecif
tabl
exampl
lesion
seen
merscov
lung
infect
necrosiscel
death
edema
hyalin
membranesfibrin
inflamm
thrombi
congest
hemorrhag
pneumonia
type
ii
hyperplasia
syncytia
lesion
instanc
lesion
present
control
treatment
group
defin
background
modeltechniqu
phenotyp
report
merscov
specif
lesion
mask
pathologist
group
assign
use
avoid
observ
bia
type
mask
method
certain
advantag
limit
tabl
see
note
common
approach
histopatholog
examin
start
low
magnif
screen
obviou
lesion
assess
qualiti
tissu
section
see
note
allow
examin
microscop
structur
airway
alveoli
alveolar
septa
air
space
vessel
pleura
examin
high
magnif
allow
screen
cellular
interstiti
compon
structur
lesion
eg
injuri
inflamm
necrosi
slide
examin
use
addit
stain
use
serial
section
defin
chang
instanc
mucu
goblet
cell
secret
air
space
highlight
special
stain
like
period
acid
schiff
glycogendeplet
tissu
alcian
blue
slide
stain
examin
group
result
need
prepar
public
qualit
character
find
import
understand
featur
diseas
includ
cellular
tropism
anatom
predisposit
natur
lesion
lead
clinic
sign
see
note
qualit
descript
lesion
includ
type
eg
epitheli
sloughingnecrosi
locat
eg
alveoli
distribut
eg
local
extens
inflamm
eg
neutrophil
cell
type
involv
eg
type
pneumocyt
qualit
featur
suffici
describ
text
exemplifi
repres
figur
use
arrow
form
annot
valuabl
figur
clarifi
guid
reader
imag
highqual
descript
help
reader
includ
review
better
understand
seen
allow
other
reproduc
studi
sever
tissu
handl
preanalyt
factor
significantli
affect
qualiti
specif
immunostain
analysi
discuss
earlier
section
paper
sever
review
similarli
mani
factor
stain
procedur
also
influenc
result
deparaffin
lack
control
tissu
optimizationvalid
techniqu
speci
batch
effect
chromogen
influenc
final
qualiti
assess
immunostain
method
standard
oper
procedur
technic
step
use
biomed
staff
significantli
mitig
mani
issu
use
posit
neg
control
tissu
batch
immunostain
tissu
help
valid
appropri
stain
also
make
clear
potenti
nonspecif
immunostain
stain
slide
examin
group
qualit
statement
immunostain
made
prepar
public
text
imag
descript
text
immunostain
receptor
viru
could
includ
cell
type
eg
type
pneumocyt
cell
integr
necrot
vs
intact
cell
subcellular
locat
eg
diffus
cytoplasm
demonstr
immunostain
use
annot
imag
strengthen
qualit
data
shown
qualit
descript
tissu
chang
use
necessari
less
applic
term
group
comparison
robust
reproduc
method
desir
criteria
sought
tissu
score
system
semiquantit
quantit
produc
data
allow
statist
analys
evalu
group
differ
see
note
importantli
score
principl
appli
tissu
lesion
gross
andor
histopatholog
well
immunostain
section
nomin
approach
score
make
quantit
measur
tissu
sampl
rather
sampl
assign
welldefin
categori
number
sampl
assign
categori
record
evalu
appropri
statist
test
simpl
mock
exampl
consid
examin
lung
wildtyp
wt
mutat
mice
presenc
absenc
edema
common
featur
dad
mous
would
assign
either
edema
fig
edema
fig
c
categori
mice
per
group
evalu
wt
group
might
nine
edema
one
without
mutat
group
three
edema
seven
without
evalu
data
use
fisher
exact
test
result
signific
differ
p
wt
mutat
mice
presenc
lesion
immunostain
similarli
assess
manner
import
clear
guidelin
threshold
distinguish
categori
semiquantit
approach
use
transform
qualit
tissu
chang
numer
score
use
specif
morpholog
criteria
semiquantit
method
sever
advantag
done
minim
technic
resourc
quickli
microscop
small
medium
studi
provid
guidanc
futur
quantit
studi
provid
complementari
data
public
commonli
use
semiquantit
method
produc
ordin
score
ordin
impli
order
progress
sever
assign
grade
defin
score
typic
four
five
grade
optim
eg
grade
well
defin
minim
ambigu
assign
sampl
use
simpl
descript
modifi
normal
rare
mild
moder
sever
discourag
differ
mean
observ
thu
limit
reproduc
score
mock
exampl
ordin
score
wt
mutat
mice
might
evalu
extent
hyalin
membran
line
alveolar
wall
score
grade
might
look
like
none
see
fig
see
fig
alveolar
wall
lung
section
ordin
score
seven
mice
per
group
produc
follow
result
wt
mutat
mice
data
statist
analyz
importantli
ordin
score
meet
assumpt
requir
parametr
test
thu
nonparametr
test
use
mock
exampl
differ
group
use
mannwhitney
utest
signific
p
quantit
method
tissu
techniqu
measur
specif
tissu
compon
length
area
volum
number
percentag
etc
quantit
method
tend
greater
precis
sensit
semiquantit
method
method
often
requir
highqual
imag
special
softwar
properli
analyz
tissu
make
method
costlier
lab
semiquantit
techniqu
grow
interest
autom
artifici
intellig
may
increas
futur
effici
costeffect
quantif
tissu
paramet
especi
larg
project
quantif
viral
lesion
immunostain
tissu
option
howev
quantif
commonli
perform
tissu
section
due
potenti
confound
factor
random
distribut
viral
inoculum
difficulti
object
quantifi
lesion
choos
perform
quantit
score
evalu
clinic
relev
anatom
compart
airway
alveoli
help
standard
assess
mock
exampl
viral
immunostain
could
evalu
percent
cell
number
mous
bronchiol
fig
respect
altern
one
could
also
assess
area
immunostain
percent
bronchiolar
epithelium
area
contrast
alveolar
compart
difficult
assess
airway
thin
wall
make
evid
necrosi
slough
immunostain
challeng
normal
analysi
one
could
assess
percent
alveoli
immunostain
fig
howev
would
like
requir
extens
time
labor
special
softwar
quantit
feasibl
import
variabl
one
could
revert
semiquantit
score
assess
immunostain
percentag
affect
alveolar
wall
use
distribut
score
system
defin
fig
one
could
score
sampl
fig
e
ordin
score
respect
mock
exampl
simpl
realiti
often
paint
complex
portrait
lesion
immunostain
distribut
fig
come
tissu
score
project
uniqu
investig
evalu
lung
sampl
determin
best
score
approach
relat
breadth
lesion
goal
project
importantli
score
perform
corrobor
possibl
data
valid
find
instanc
group
immunostain
group
b
could
valid
elisa
western
blot
whole
lung
homogen
altern
lesion
sever
could
corrobor
measur
clinic
data
see
note
valid
help
give
confid
data
rigor
reproduc
inappropri
use
pair
ttest
shop
signific
two
issu
slip
publish
literatur
potenti
compromis
interpret
reproduc
studi
variou
score
method
statist
analys
data
involv
collabor
expertis
statistician
abl
identifi
relev
test
confid
evalu
group
differ
examin
infect
lung
tissu
histopatholog
immunostain
common
need
approach
studi
viral
lung
infect
especi
emerg
coronavirus
like
merscov
follow
principl
concept
help
guid
lead
studi
valid
reproduc
data
ideal
pathologist
familiar
model
avail
lab
evalu
experiment
tissu
pathologist
collabor
sought
perform
review
result
examin
prior
submiss
public
prevent
public
data
flaw
need
subsequ
retract
mask
import
prevent
potenti
bia
observ
pathologist
tabl
new
project
postexamin
prefer
help
pathologist
understand
goal
experiment
design
project
well
see
qualiti
scope
lesionsstain
research
project
pathologist
familiar
model
mask
group
fashion
maxim
interpret
power
pathologist
screen
biolog
relev
chang
groupspecif
manner
comprehens
mask
often
discourag
effect
constrain
abil
pathologist
defin
relev
versu
unconnect
data
therefor
limit
sensit
specif
patholog
data
evalu
slide
treatment
control
group
prior
detail
examin
use
give
pathologist
overview
primer
type
scope
sever
lesionsstain
detail
examin
tissu
allow
extrapol
qualit
descript
data
question
regard
cellstissu
address
specif
stainsthes
could
done
time
corroborateclarifi
descript
find
biolog
relev
lesion
defin
project
groupspecif
chang
may
evalu
semiquantit
quantit
score
semiquantit
approach
often
done
initi
result
use
screen
tool
set
primari
score
approach
use
primarysupplement
data
report
group
differ
lesion
stain
quantit
approach
may
perform
microscop
eg
cell
count
autom
digit
imag
special
softwar
regardless
mask
method
see
note
often
use
score
slide
random
mask
fashion
one
sit
prevent
diagnost
drift
score
sometim
benefici
take
score
data
see
differ
morpholog
detect
respect
group
pathologist
see
differ
give
confid
score
approach
final
interpret
rais
question
score
method
effect
report
patholog
data
requir
transpar
method
number
anim
statist
analys
etc
produc
graph
score
data
match
imag
annot
power
tool
convey
result
reader
